A detailed history of Money Concepts Capital Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Money Concepts Capital Corp holds 41,910 shares of ABBV stock, worth $8.11 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares
41,910
Previous 42,441 1.25%
Holding current value
$8.11 Million
Previous $7.73 Million 6.99%
% of portfolio
0.65%
Previous 0.73%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

SELL
$154.79 - $180.76 $82,193 - $95,983
-531 Reduced 1.25%
41,910 $7.19 Million
Q1 2024

May 01, 2024

SELL
$159.82 - $182.1 $150,710 - $171,720
-943 Reduced 2.17%
42,441 $7.73 Million
Q4 2023

Feb 12, 2024

SELL
$137.6 - $154.97 $131,132 - $147,686
-953 Reduced 2.15%
43,384 $6.72 Million
Q3 2023

Oct 31, 2023

SELL
$133.59 - $154.65 $183,018 - $211,870
-1,370 Reduced 3.0%
44,337 $6.61 Million
Q2 2023

Jul 31, 2023

SELL
$132.51 - $164.9 $7.06 Million - $8.78 Million
-53,256 Reduced 53.81%
45,707 $6.16 Million
Q1 2023

May 01, 2023

SELL
$144.61 - $166.54 $12.5 Million - $14.4 Million
-86,370 Reduced 46.6%
98,963 $15.8 Million
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $12.7 Million - $15.3 Million
92,053 Added 98.68%
185,333 $30 Million
Q3 2022

Oct 27, 2022

BUY
$134.21 - $153.93 $6.03 Million - $6.91 Million
44,909 Added 92.84%
93,280 $12.5 Million
Q2 2022

Jul 18, 2022

SELL
$137.62 - $174.96 $9.3 Million - $11.8 Million
-67,551 Reduced 58.27%
48,371 $7.44 Million
Q1 2022

May 13, 2022

BUY
$131.98 - $163.75 $8.69 Million - $10.8 Million
65,825 Added 131.4%
115,922 $18.8 Million
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $238,064 - $301,220
2,216 Added 4.63%
50,097 $6.78 Million
Q1 2021

May 17, 2021

BUY
$102.3 - $112.62 $62,607 - $68,923
612 Added 1.29%
47,881 $5.18 Million
Q4 2020

May 17, 2021

BUY
$80.49 - $108.67 $3.8 Million - $5.14 Million
47,269 New
47,269 $5.07 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $342B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Money Concepts Capital Corp Portfolio

Follow Money Concepts Capital Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Money Concepts Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Money Concepts Capital Corp with notifications on news.